Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Company Description
Datalink Corp designs, installs and supports data center solutions for medium and large-sized companies. The company was founded in 1958 and has a market cap of $162 million.
Although Datalink has been strong for most of 2011, shares got an extra boost on July 20 after the company reported strong Q2 results that came in well ahead of expectations.
Second-Quarter Results
Revenue for the period was up 26% from last year to $90 million. Earnings also looked great, coming in at 18 cents, 157% ahead of the Zacks Consensus Estimate, where the company has an average earnings surprise of 56% over the last four quarters.
The good quarter was driven by a sharp increase in high-dollar sales, with 36 customers purchasing over $1 million in products or services in the first six months of the year, up from 23 in the same period last year.
Financial Profile
Datalink has used its earnings momentum to strengthen its financial profile, with cash and short-term investments up $21 million from last year to $33 million against no debt.
Estimates
We saw some bullish movement in estimates off the good quarter, with the current year adding 16 cents to 56 cents while the next-year estimate gained 16 cents to 61 cents, a 10% growth projection.
Valaution
But in spite of the gains, the valuation picture still looks good, with a forward of 16X in line with its peer average.
12-Month Chart
On the chart, shares jumped into a new multi-year high on the good quarter before recently pulling back a bit with the market. Look for support from the long-term trend on any weakness, take a look below.
Michael Vodicka is the Momentum Stock Strategist for Zacks.com. He is also the Editor in charge of the Zacks Momentum Trader Service.
Read the full reports :
Snapshot Report on DTLK